Just when you might have thought that there was a light at the end of the COVID tunnel, the global pandemic is back in full force with the highly contagious delta variant. We have not yet reached herd immunity and there has been a slowdown in the number of people getting vaccinated and there has been some significant vaccine hesitancy. Perhaps if you know your COVID-19 risk in developing severe symptoms, you’d be more interested in getting the vaccine?
If you live in the United States, chances are, you are living in such a plentiful part of the world that vaccines are in such supply that there is a stockpile many times over what is needed to fully vaccinate the population. What if vaccines could be rolled out by need instead of seemingly random or by rich and poor? Not just by age and “high risk,” however. Welcome to the new frontier of the future of healthcare – the world of genetics and genetic testing. Proper genetic testing of the population can effectively test across numerous comorbidities to see which people would develop severe COVID symptoms.